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The stability and infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in liquid samples are of great concern to virus transmission via common
beverages and sewage water. Here, we investigated the stability of SARS-CoV-2 in 32
liquids including common beverages, bodily fluids, and commonly used viral transport
media. Our results showed that the infectious virus could be recovered up to 77-days
from common beverages including milk and water. Viral RNA could be detected at high
levels in all samples up to 28-days, indicating that while viral RNA demonstrates higher
stability than infectivity, viral RNA levels do not reflect the infectious capability of SARS-
CoV-2. These results indicate that SARS-CoV-2 is highly stable in optimal conditions and
a sufficient control measure is needed in reducing the risk of exposure and controlling
and preventing future outbreaks.
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INTRODUCTION
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA has been detected
in surfaces and environment and surfaces due to contact with carrier (Kampf et al., 2020; van
Doremalen et al., 2020). SARS-CoV-2 can survive in suspension and in aerosols in the environment
for a limited time and the virus is very stable in favorable environments (Chin et al., 2020). At
refrigeration temperatures (4◦C), SARS-CoV-1 remains infectious up to 9 days (Rabenau et al.,
2005). In a transportation medium, there was a limited reduction in infectious SARS-CoV-2 held
at 4◦C for up to 14 days (Chin et al., 2020). In this context, SARS-CoV-2 remained infectious for 3
weeks in spiked pieces of refrigerated chicken, pork, and salmon (Fisher et al., 2020). In industrial
production, SARS-CoV-2 RNA has been detected in dairy products, including milk powder and
ice cream, leading to disruptions in the food supply chain (Liew, 2021). While the persistence
of viral RNA on surfaces and in food could contribute to potential positive test results, a robust
risk evaluation should include an assay that is capable of differentiating between infectious and
non-infectious virions. To date, there have been limited studies on viral infectivity in common
beverages and bodily fluids. In this context, the evaluation of virus stability together with infectivity
in commonly available beverages are of high importance to the risk assessment of outbreak
control and prevention.
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A current tool for the identification and assessment of SARS-
CoV-2 includes reverse-transcriptase PCR (RT-PCR) for the
detection of the virus genome and virus isolation. RT-PCR
provides rapid assessment but offers no information on virus
infectivity and is occasionally prone to false-positive results
(Surkova et al., 2020; Wikramaratna et al., 2020). While laborious
compared to the RT-PCR method, virus titration by using cell
culture is the most direct method for the evaluation of virus
infectivity. In this study, the infectivity of SARS-CoV-2 in 32
commercial beverage and bodily fluids was quantitated by using
RT-PCR and a conventional plaque assay by cell culture; tested for
infectivity up to 77 days after incubation, the aim was to evaluate
the stability and infectivity of SARS-CoV-2 in liquid suspension.
MATERIALS AND METHODS
Virus and Cell Lines
SARS-CoV-2 (TY-WK-521/2020 strain) was propagated on Vero
9013 cells at 37◦C in 5% CO2 for up to 6 days. Vero 9013
cells (Japan Health Science Research Resources TBankT) were
cultured as previously described in Eagle’s Minimum Essential
Medium (EMEM, Sigma, St. Louis, MO) supplemented with
heat-inactivated 10% fetal calf serum (FCS, Sigma) without
antibiotics at 37◦C in 5% CO2 (Balingit et al., 2020). Commercial
beverages were obtained from local stores. Pooled saliva and
urine used as body fluids samples were obtained from Innovative
Research, Inc. (Novi, MI, United States). At set time points,
samples were collected for the infectivity test by plaque assay
and genomic viral RNA quantitation by quantitative real-time
RT-PCR (qRT-PCR) (Corman et al., 2020; Le et al., 2020).
Plaque Assay
A plaque assay was performed to determine the levels of
infectious virus particles (Cooper, 1962). Infection assay using
SARS-CoV-2 was performed in the BSL-3 facility at the Institute
of Tropical Medicine, Nagasaki University. In this study, 50 µL
of virus culture (2 × 106 PFU/mL) was inoculated into 950
µL of the liquid sample (final virus concentration was 1 × 105
PFU/mL) and incubated at 4◦C. In clinical samples, the infectious
virus was isolated from the nasopharyngeal swabs of COVID 19
patients at titers between 105 PFU/mL to 107PFU/mL (Lescure,
2020), suggesting that virus shedding occurs between these levels
during natural infection. Thus, the liquid samples in this study
were spiked at concentrations that show virus shedding during
natural infection at a titer of 2 × 106 PFU/mL of virus (final
concentration: 1 × 105 PFU/mL). Briefly, SARS-CoV-2 spiked
liquid samples were incubated at 4◦C were collected at each
time point and serially diluted in the EMEM (dilution ratio of
1:10–1:103). A total of 100 µL of serially diluted sample was
inoculated onto monolayers of Vero cells in a 12-well plate. Next,
the plates were incubated at 37◦C in 5% CO2 up to 40 min, and,
after incubation, 2 mL of overlay media [5 g of Methylcellulose
(Wako Pure Chemical Industries Ltd., Osaka, Japan), 12 g of
Avicel RC 591 (FMC Biopolymer, United States), and 9.4 g of
EMEM powder were dissolved in 1 L of DDW] was added to
each well. After 3 days post-infection, cells were fixed with 4%
paraformaldehyde and stained with 0.25% crystal violet (Wako
Pure Chemical Industries) (Balingit et al., 2020). The number of
plaques was counted with the naked eye, and the viral titer was
defined as plaque-forming units per milliliter (PFU/mL).
Viral RNA Quantitation
Viral RNA was extracted from 100 µL of liquid samples using
Quick Viral RNA kit (Zymo research, CA, United States), and
the SARS-CoV-2 E gene was amplified by qRT-PCR (Fisher et al.,
2020; Wikramaratna et al., 2020). The PCR master mix consisted
of 2.5 µL of RNA, 5 µL of TaqMan Fast Virus 1-Step Master
Mix (Applied Biosystems, CA, United States), 0.25 µL of 100 µM
forward and reverse primer, 0.5 µL of 10 µM probe, and 9 µL
nuclease-free water. Viral RNA was subjected to quantitative RT-
PCR as previously described (Corman et al., 2020; Le et al., 2020).
The viral RNA levels were defined as log 10 copies number/mL.
Statistical Analysis
All virus titration assays (plaque titration and RT-qPCR) assays
were performed in duplicates, and all experiments were at least
performed twice. Data were analyzed by using GraphPad Prism
version 6.07 (GraphPad software, La Jolla, CA, United States). For
the determination of P-values of virus titers of the same samples,
a paired Student’s t-test was used. Unpaired t-test was used for
comparison of virus titers as determined by plaque assay and
RT-PCR. A P-value of less than 0.05 (P < 0.05) is considered
significant. The half-life value (day) of the infectious virus in each
liquid sample was calculated using; t 1/2 = log102/k, k = decay
constant (Riddell et al., 2020).
RESULTS
A total of 32 types of liquid samples were used in this
experiment. The spiked samples incubated at 4◦C were collected
at 13 incubation time points. Infectious virus and viral RNA
were detected by plaque assay and qRT-PCR, respectively.
The infectious virus value was represented as a plaque
forming unit (PFU)/mL.
Infectious virus could be recovered between day 7 to day
35 from some beverages, including milk, fruit juices, alcoholic
beverages (alcohol content < 16%), and water, and bodily fluids
(saliva and urine, Table 1). Of the 32 samples tested, in four
liquid samples, infectious virus particles could be detected up to
day 77 of the incubation time point. Retention of viral infectivity
varied according to the type of beverage and the incubation
time (day 0, Table 1). There was a more than 10-fold reduction
in the infectious titer in the 28 types of liquid samples tested.
Overall, virus infectivity was reduced in most of the samples
tested but remained infectious in 15/32 (46.9%), 14/32 (43.7%),
and 11/32 (34.4%) of the samples tested at 14, 21, and 28 days,
respectively. In this context, there was no significant reduction
in SARS-CoV-2 infectious virus titers in common beverages,
including milk and soy milk samples, up to day 28 of incubation
(Table 1). In alcoholic beverage samples, infectious virus could
be detected in three of the five spiked samples tested after 7
days of incubation. Viral RNA was detected in all of the samples

























TABLE 1 | Stability and infectivity of SARS-CoV-2 in different beverages and bodily fluids over an 11-week period.
Virus titer (log10 PFU/mL)
Sample Day 0 Day 3 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 Day 49 Day 56 Day 63 Day 70 Day 77
Group 1 water
Mineral watera 3.7 ± 0.2 3.5 ± 0.1 3.7 ± 0.1 3.6 ± 0.4 3.6 ± 0.1 3.1 ± 0.0 3.1 ± 0.0 ND NT NT NT NT NT
Tap watera 4.6 ± 0.0 4.7 ± 0.1 4.8 ± 0.2 4.7 ± 0.0 4.3 ± 0.1 NT 3.9 ± 0.2 NT 3.5 ± 0.0 3.6 ± 0.0 NT NT NT
Distilled water 3.9 ± 0.1 3.4 ± 0.0 4.1 ± 0.2 4.1 ± 0.1 3.9 ± 0.2 3.6 ± 0.2 3.5 ± 0.0 3.4 ± 0.2 3.2 ± 0.0 3.4 ± 0.0 3.5 ± 0.0 3.0 ± 0.2 2.7 ± 0.1
Group 2 milk
Milk 3.6 ± 0.1 3.1 ± 0.1 3.8 ± 0.1 3.7 ± 0.3 3.5 ± 0.1 3.3 ± 0.2 3.3 ± 0.0 3.1 ± 0.1 2.9 ± 0.1 3.2 ± 0.1 3.0 ± 0.2 2.2 ± 0.2 2.5 ± 0.2
Soy milk 3.5 ± 0.0 3.1 ± 0.1 4.4 ± 0.4 3.8 ± 0.0 4.0 ± 0.3 4.2 ± 0.5 2.9 ± 0.2 3.7 ± 0.2 2.7 ± 0.3 2.7 ± 0.1 2.9 ± 0.2 2.5 ± 0.0 2.4 ± 0.1
Yogurt drink 3.5 ± 0.0 2.9 ± 0.2 2.5 ± 0.2 ND ND ND ND NT NT NT NT NT NT
Milk-coffee 3.2 ± 0.2 3.5 ± 0.0 2.9 ± 0.0 2.0d 2.2 ± 0.2 ND ND NT NT NT NT NT NT
Cocoa 3.4 ± 0.2 3.6 ± 0.0 3.1 ± 0.2 2.6d ND ND ND NT NT NT NT NT NT
Group 3 juice/coffee
Apple juice 3.2 ± 0.9 3.7 ± 0.2 ND ND ND ND ND NT NT NT NT NT NT
Orange juice 3.3 ± 0.1 3.7 ± 0.1 3.3 ± 0.1 2.4d ND ND ND NT NT NT NT NT NT
Tomato juice 3.7 ± 0.0 3.7 ± 0.0 3.5 ± 0.1 ND ND ND ND NT NT NT NT NT NT
Flavored fruit juice 3.6 ± 0.1 3.4 ± 0.0 1.4 ± 1.7 ND ND ND ND NT NT NT NT NT NT
Black coffee 3.0 ± 0.2 3.3 ± 0.2 2.8 ± 0.0 ND ND ND ND NT NT NT NT NT NT
Group 4 carbonated beverage
Cola 2.5 ± 0.2 2.3d ND ND ND ND ND NT NT NT NT NT NT
Lemon-lime carbonated beverage 2.2 ± 0.3 ND ND ND ND ND ND NT NT NT NT NT NT
Group 5 tea
Green tea 2.7d 2.0d ND ND ND ND ND NT NT NT NT NT NT
Black tea (Oolong tea) NDc ND ND ND ND ND ND NT NT NT NT NT NT
Herbal tea (Artemisia capillaris) ND ND ND ND ND ND ND NT NT NT NT NT NT
Group 6 alcohol beverage
Beer, 5%b 3.6 ± 0.1 3.8 ± 0.1 3.5 ± 0.0 3.1 ± 0.1 3.1 ± 0.1 2.8 ± 0.3 2.3 ± 0.0 2.2 ± 0.3 2.0 ± 0.0 ND NT NT NT
Sparkling sake, 5%b 3.3 ± 0.3 2.8 ± 0.1 ND ND ND ND ND NT NT NT NT NT NT
Carbonated distilled beverage (shochu), 9%b 3.4 ± 0.2 3.7 ± 0.0 3.9 ± 0.0 3.2 ± 0.0 3.1 ± 0.3 2.8 ± 0.1 ND NT NT NT NT NT NT
White wine, 11%b ND ND ND ND ND ND ND NT NT NT NT NT NT
Japanese wine (sake), 15.6%b 3.4 ± 0.3 2.9 ± 0.0 3.1 ± 0.1 2.3d 2.7 ± 0.6 2.1 ± 0.2 ND NT NT NT NT NT NT
Group 7 health beverage
Sports drink P 3.3 ± 0.2 2.6 ± 0.2 2.0d ND ND ND ND NT NT NT NT NT NT
Amino sports beverage 2.8 ± 0.2 ND ND ND ND ND ND NT NT NT NT NT NT
Multivitamin beverage 3.3 ± 0.3 2.2 ± 0.2 2.0 ± 0.0 ND ND ND ND NT NT NT NT NT NT
Energy tonic ND ND ND ND ND ND ND NT NT NT NT NT NT
Vinegar beverage 3.8 ± 0.3 3.5 ± 0.1 2.8 ± 0.0 ND ND ND ND NT NT NT NT NT NT
Group 8 bodily fluid
Salivac NTf 3.9 ± 0.0 3.6 ± 0.0 3.2 ± 0.1 2.5 ± 0.3 2.0 ± 0.0 ND NT NT NT NT NT NT
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tested, and the difference in the viral RNA levels between non-
infectious and infectious samples was not significant by using
the t-test (P infectious vs.non−infectious, day7 = 0.75). Viral RNA
could still be detected at high levels in samples that did not
demonstrate infectivity, concurring with that of previous studies
that have shown that viral RNA levels do not reflect infectivity
(Table 2). Between infectious and non-infectious samples, or
according to the incubation period, viral RNA levels did not
decrease significantly by the t-test (P days0 vs. 28 = 0.33) and could
be detected at high levels (>log10 10 genome copies/mL) at up to
1 month of incubation (Table 2). The half-life value of infectious
SARS-CoV-2 in the water and milk group, bodily fluids and viral
transport media were, however, had longer half-lives compared
to other beverage groups (Table 3).
DISCUSSION
Our data showed that SARS-CoV-2 infectivity was stable in
commonly consumed beverages and bodily fluids at optimal
storage conditions. These results demonstrated virus stability
even in beverages with significant alcohol content, such as
Japanese wine sake (15.6% of alcohol content). While there
has been little evidence of the isolation of SARS-CoV-2 from
sewage water, infectious virus was detected in spiked tap
water and bodily fluids up to 2-months after incubation in
which their half-life values were between 4.0 and 52.7 days
(Table 3), indicating prolonged virus stability in drinking water
and possibly wastewater. Viral RNA could still be detected at
high levels in samples that did not demonstrate infectivity,
concurring with that of previous studies that viral RNA levels
do not reflect infectivity. Of note, in a similar experiment
using a dengue virus (Supplementary Table 1), no infectious
particles were detected after inoculation in all of the spiked-
alcoholic beverage samples. Infectious SARS-CoV-2 could still be
detected for the length of the experiment, of up to 77 days, in
common beverages, including water and milk. While SARS-CoV-
2 suspended in water, milk, and soy milk remained infectious
up to day 77 of refrigeration, infectious virus particles were not
detected in acidic beverages (fruit juices, cola, vinegar drink,
and white wine) by day 7 after refrigeration. Of note, infectious
virus particles were not detected in tea beverages immediately
after incubation, indicating the presence of active compounds
that may hamper SARS-CoV-2 infectivity in vitro. In all, the
study provided insights into SARS-CoV-2 infectivity in common
commercial beverages, with the longest follow-up period to
date being 77 days, and it also demonstrated that SARS-CoV-
2 has great stability in a range of environmental conditions.
While plaque assay is laborious and requires high-level biosafety
containment (BSL-3 facility), additional means of monitoring,
including quantification of viral proteins by mass spectrometry
(Gouveia et al., 2020), may be useful as proxies for infectious
virus particles, and will be complementary in monitoring virus
infectivity and potential risks.
Although aerosol transmission remains the main route of
transmission for SARS-CoV-2, other routes of transmission
including surface contact and fecal–oral route could not be
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TABLE 2 | SARS-CoV-2 genome levels in different beverages and bodily fluids as determined by real-time PCR.
Viral RNA titer (log10 genome copies/mL)a
Sample Day 0 Day 3 Day 7 Day 14 Day 28
Group 1 water
Mineral water 10.8 ± 6.8 11.0 ± 7.0 9.9 ± 6.8 10.1 ± 6.6 11.0 ± 6.1
Distilled water 11.0 ± 7.3 11.1 ± 7.5 11.3 ± 8.0 10.8 ± 6.4 10.8 ± 5.1
Group 2 milk
Milk 10.9 ± 6.4 11.4 ± 7.6 9.8 ± 6.3 10.8 ± 5.7 10.5 ± 5.9
Soy milk 10.0 ± 6.3 10.3 ± 5.9 10.1 ± 5.9 10.0 ± 6.5 10.1 ± 5.6
Yogurt drink 10.3 ± 6.3 10.8 ± 6.0 10.1 ± 6.4 10.3 ± 6.1 10.6 ± 6.3
Milk-coffee 10.4 ± 6.0 10.9 ± 6.2 9.4 ± 5.6 9.0 ± 5.5 10.2 ± 6.1
Cocoa 9.3 ± 5.8 10.7 ± 6.7 9.2 ± 6.3 9.5 ± 6.1 10.3 ± 5.7
Group 3 juice/coffee
Apple juice 10.4 ± 6.3 10.3 ± 5.3 10.2 ± 6.6 10.3 ± 5.4 10.6 ± 5.5
Orange juice 10.3 ± 7.0 10.8 ± 6.2 10.8 ± 6.1 10.8 ± 6.7 10.0 ± 6.1
Tomato juice 9.3 ± 5.6 10.0 ± 5.8 10.7 ± 6.6 10.7 ± 6.0 10.1 ± 5.4
Flavored fruit juice 11.1 ± 7.5 10.2 ± 5.2 10.2 ± 6.1 10.8 ± 5.9 10.3 ± 5.8
Black coffee 11.0 ± 7.3 11.5 ± 5.9 10.0 ± 6.2 10.8 ± 6.3 10.8 ± 6.0
Group 4 carbonated beverage
Cola 10.4 ± 4.6 10.9 ± 4.4 11.1 ± 6.5 10.1 ± 5.5 10.7 ± 6.3
Lemon-lime carbonated beverage 10.6 ± 6.9 10.3 ± 6.1 9.6 ± 5.6 9.9 ± 5.9 10.9 ± 6.7
Group 5 tea
Green tea 11.1 ± 7.2 11.2 ± 6.2 10.2 ± 6.6 10.8 ± 6.9 10.6 ± 5.8
Black tea (Oolong tea) 11.1 ± 6.7 11.6 ± 7.4 10.0 ± 4.9 10.9 ± 6.6 10.1 ± 5.4
Herbal tea (Artemisia capillaris) 11.2 ± 7.1 11.3 ± 6.0 10.9 ± 7.0 10.5 ± 5.5 10.1 ± 4.1
Group 6 alcohol beverage
Beer, 5%b 11.4 ± 8.0 11.1 ± 7.3 10.7 ± 7.0 10.6 ± 6.0 10.8 ± 5.4
Sparkling sake, 5%a 10.2 ± 5.9 11.1 ± 6.0 10.9 ± 7.0 9.8 ± 4.9 10.9 ± 4.5
Carbonated distilled beverage (shochu), 9%a 10.6 ± 5.7 11.5 ± 6.9 11.2 ± 7.2 9.7 ± 5.4 10.8 ± 6.4
White wine, 11%a 10.9 ± 7.1 10.8 ± 6.8 9.6 ± 5.2 10.0 ± 5.5 10.6 ± 6.4
Japanese wine (sake), 15.6%a 10.8 ± 5.3 10.5 ± 6.6 9.7 ± 6.7 10.2 ± 6.2 10.4 ± 5.9
Group 7 health beverage
Sports drink P 10.8 ± 6.6 11.5 ± 7.4 11.1 ± 7.5 10.9 ± 6.6 10.8 ± 6.1
Amino sports beverage 10.5 ± 6.4 11.0 ± 5.9 10.9 ± 6.9 10.5 ± 6.7 10.7 ± 5.8
Multivitamin beverage 10.0 ± 5.7 9.5 ± 4.7 9.9 ± 6.6 10.0 ± 4.7 9.3 ± 5.5
Energy tonic 10.9 ± 5.8 10.9 ± 6.6 9.7 ± 5.2 9.9 ± 5.7 10.8 ± 6.9
Vinegar beverage 9.7 ± 5.1 10.9 ± 6.7 9.9 ± 5.6 10.6 ± 5.3 10.7 ± 5.4
Group 8 bodily fluid
Salivab NTc 9.7 ± 6.5 10.5 ± 7.3 11.0 ± 6.2 10.9 ± 6.3
Urineb 10.5 ± 6.2 10.9 ± 6.7 10.2 ± 7.2 10.2 ± 6.5 11.1 ± 5.5
Group 9 viral transport media
PBS 11.2 ± 7.5 11.2 ± 6.8 10.0 ± 5.2 11.0 ± 6.7 10.9 ± 5.5
10% FBS/MEM 11.1 ± 7.1 11.7 ± 8.1 11.5 ± 7.8 11.0 ± 6.3 10.9 ± 5.5
Viral genome levels are expressed as mean ± standard deviation log10 genome copies/mL. Genome level was determined by real-time PCR by using the E-gene for
detection. All experiments were performed using at least two independent duplicates.
a Indicates alcohol content.
bPooled saliva and urine were obtained from Innovative Research, Inc. (Novi, MI, United States).
FBS/MEM, 10% fetal bovine serum with minimum essential medium; PBS, phosphate-buffered saline.
cNT indicates not tested.
ruled out. In this context, the possible risk of Middle East
respiratory syndrome (MERS) transmission in contaminated
milk has been suggested previously (van Doremalen et al., 2014).
While, SARS-CoV-2 RNA has been detected in beverages and
biological samples including urine of some patients (Wang
et al., 2020; Wu et al., 2020; Xiao et al., 2020), there is
limited evidence of transmission by SARS-CoV-2 through food
consumption or fecal–oral transmission (Xiao et al., 2020). As
human gut enterocytes have been reported to be permissive to
the replication of SARS-CoV-2 (Lamers et al., 2020), these studies
imply that further studies would be needed to determine virus
transmissibility through the fecal–oral route. Viral transmission
may be affected by various environmental factors, including
temperature, humidity, and route of transmission (Chin et al.,
2020; Ratnesar-Shumate et al., 2020; Ren et al., 2020).
Additionally, with the current industry standards for food
manufacturing (Anelich, 2020), the risk of food contamination
through exposure to contaminated products and contamination
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TABLE 3 | Half-life value (Day) of SARS-CoV-2 spiked in different beverages
and bodily fluids.















Flavored fruit juice 2.6
Black coffee 21
Group 4 carbonated beverage
Cola 4.5
Lemon-lime carbonated beverage 4.0
Group 5 tea
Green tea 1.2
Black tea (Oolong tea) NTc
Herbal tea (Artemisia capillaris) NT
Group 6 alcohol bevarage
Beer, 5%a 9.2
Sparkling sake, 5%a 1.6
Carbonated distilled beverage (shochu), 9%a 14
White wine, 11%a NT
Japanese wine (sake), 15.6%a 6.5
Group 7 health beverage
Sports drink P 1.6




Group 8 bodily fluid
Salivab 4.0
Urineb 10.5
Group 9 viral transport media
PBS 17.5
10% FBS/MEM 15.4
The half-life value (day) of the infectious virus in each liquid sample was calculated
using;
Half-life value (t 1/2) = log102/k, k = decay constant.
a Indicates alcohol content.
bPooled saliva and urine were obtained from Innovative Research, Inc. (Novi, MI,
United States).
FBS/MEM, 10% fetal bovine serum with minimum essential medium; PBS,
phosphate-buffered saline.
cNT indicates not tested.
of the production line is likely low and thus, public health threat
due to the consumption of contaminated food is likely limited.
However, given that commercially produced beverages are often
produced on a large-scale and exported to other countries, the
finding of this study demonstrating that SARS-CoV-2 is stable
in optimal conditions for more than 2 months indicates that a
sufficient amount of infectious virus may potentially lead to virus
transmission, and this points to possible exposure through the
handling of contaminated food and beverages. Newer approaches
and paradigm shift to the global food and beverage supply chain,
including control measures including routine monitoring and
disinfection, will be key in reducing the risk of exposure and in
outbreak control and prevention.
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